Related Experiment Video
Updated: Jun 21, 2025

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
Published on: June 15, 2018
The Regulation of Pyroptosis and Ferroptosis by MicroRNAs in Cardiovascular Diseases
Akram Shariati1, Venus Shahabi Raberi2, Mehdi Masumi2
1Department of Cardiology, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran.
Abstract:
Cardiovascular diseases (CVDs) are considered the most prevalent noncommunicable disease and the leading cause of death worldwide. A plethora of evidence has revealed that microRNAs (miRNAs) could control the inhibition or progression of CVDs by regulating pivotal cell processes ranging from metabolism and homeostasis to programmed cell death (PCD). Pyroptosis and ferroptosis are two major types of nonapoptotic PCDs involved in the pathogenesis of heart failure. However, no study has discussed the crosstalk between miRNAs and these two types of PCDs in the CVDs. The current review demonstrated that different types of miRNAs can regulate both ferroptosis and pyroptosis and thereby affect CVDs progression and inhibition. Altogether, the discussed content encourages further studies to confirm that mentioned pathways are suitable to be considered as novel therapeutic approaches against CVDs.
Insights
MicroRNAs (miRNAs) regulate programmed cell death pathways like pyroptosis and ferroptosis, impacting cardiovascular diseases (CVDs). Understanding this crosstalk offers potential new therapeutic strategies for heart failure.
Area of Science:
- Biomedical science
- Molecular biology
- Cardiology
Background:
- Cardiovascular diseases (CVDs) are the leading global cause of death.
- MicroRNAs (miRNAs) are key regulators of cellular processes, including metabolism, homeostasis, and programmed cell death (PCD).
- Pyroptosis and ferroptosis are critical non-apoptotic PCD types implicated in heart failure pathogenesis.
Purpose of the Study:
- To review the intricate relationship between miRNAs and pyroptosis and ferroptosis in the context of CVDs.
- To explore how miRNAs modulate these specific PCD pathways in cardiovascular disease.
- To identify potential therapeutic targets within miRNA-regulated PCD pathways for CVD treatment.
Main Methods:
- Comprehensive literature review of studies investigating miRNAs, pyroptosis, ferroptosis, and CVDs.
- Analysis of existing research on the regulatory roles of miRNAs in non-apoptotic cell death.
- Synthesis of findings to elucidate the crosstalk between miRNAs and PCD in cardiovascular pathogenesis.
Main Results:
- Evidence indicates that various miRNAs can regulate both pyroptosis and ferroptosis.
- These miRNA-mediated regulatory actions influence the progression and inhibition of CVDs.
- The interplay between miRNAs and these PCDs is a significant factor in heart failure development.
Conclusions:
- The crosstalk between miRNAs and pyroptosis/ferroptosis pathways is crucial in CVDs.
- Targeting these miRNA-regulated PCD pathways presents a promising avenue for novel therapeutic interventions.
- Further research is warranted to validate these pathways as effective therapeutic strategies against cardiovascular diseases.
More Related Videos
Related Concept Videos
MicroRNAs
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Regulation of Angiogenesis and Blood Supply
Regulation of the Unfolded Protein Response

